Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb;62(1):103521.
doi: 10.1016/j.transci.2022.103521. Epub 2022 Aug 4.

Rethinking the role of COVID-19 convalescent plasma in the critically ill

Arturo Casadevall  1 , Liise-Anne Pirofski  2
Affiliations

Rethinking the role of COVID-19 convalescent plasma in the critically ill

Arturo Casadevall et al. Transfus Apher Sci. 2023 Feb.
No abstract available

Keywords: COVID-19; Convalescent plasma; SARS-CoV-2.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Casadevall A., Pirofski L.A., Joyner M.J. The principles of antibody therapy for infectious diseases with relevance for COVID-19. mBio. 2021;12(2) - PMC - PubMed
    1. Libster R., Perez Marc G., Wappner D., et al. Early high-titer plasma therapy to prevent severe covid-19 in older adults. N Engl J Med. 2021;384(7):610–618. - PMC - PubMed
    1. Sullivan D.J., Gebo K.A., Shoham S., et al. Early outpatient treatment for covid-19 with convalescent plasma. N Engl J Med. 2022 - PMC - PubMed
    1. Ortigoza M.B., Yoon H., Goldfeld K.S., et al. Efficacy and safety of COVID-19 convalescent plasma in hospitalized patients: a randomized clinical trial. JAMA Intern Med. 2021 - PMC - PubMed
    1. Chowdhry M., Hussain M., Singh P., et al. Convalescent plasma – an insight into a novel treatment of covid-19 ICU patients. Transfus Apher Sci: J World Apher Assoc: J Eur Soc Haemapheresis. 2022 - PMC - PubMed

Substances